Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nucleic acid delivery for therapeutic applications
Akash Gupta, Jason L. Andresen, Rajith S. Manan, et al.
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113834-113834
Closed Access | Times Cited: 214

Showing 1-25 of 214 citing articles:

The landscape of mRNA nanomedicine
Xiangang Huang, Na Kong, Xingcai Zhang, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2273-2287
Open Access | Times Cited: 305
The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies
Ruixue Bai, Yunong Li, Lingyan Jian, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 147
The role of microRNAs in neurodegenerative diseases: a review
Shijie Li, Zhixin Lei, Taolei Sun
Cell Biology and Toxicology (2022) Vol. 39, Iss. 1, pp. 53-83
Open Access | Times Cited: 71
Engineering siRNA therapeutics: challenges and strategies
Syed Saqib Ali Zaidi, Faria Fatima, Syed Aqib Ali Zaidi, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 60
Recent advances in using liposomes for delivery of nucleic acid-based therapeutics
Hamdi Nsairat, Walhan Alshaer, Fadwa Odeh, et al.
OpenNano (2023) Vol. 11, pp. 100132-100132
Open Access | Times Cited: 57
Chemically Modified Platforms for Better RNA Therapeutics
Yesi Shi, Xueyan Zhen, Yiming Zhang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 3, pp. 929-1033
Closed Access | Times Cited: 39
Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol
Michael Neary, Lianne M. Mulder, Piotr S. Kowalski, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 812-833
Open Access | Times Cited: 15
Exosomes and non-coding RNAs: Exploring their roles in human myocardial dysfunction
Magdalena Kulus, Maryam Farzaneh, Mohadeseh Sheykhi-Sabzehpoush, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117853-117853
Closed Access | Times Cited: 1
Messenger RNA vaccines for cancer immunotherapy: progress promotes promise
Amanda L. Huff, Elizabeth M. Jaffee, Neeha Zaidi
Journal of Clinical Investigation (2022) Vol. 132, Iss. 6
Open Access | Times Cited: 38
The interplay between PEGylated nanoparticles and blood immune system
Guo Chen, Haoyang Yuan, Yuxiu Wang, et al.
Advanced Drug Delivery Reviews (2023) Vol. 200, pp. 115044-115044
Closed Access | Times Cited: 36
Physiological Barriers and Strategies of Lipid‐Based Nanoparticles for Nucleic Acid Drug Delivery
Mingdi Hu, Xiaoyan Li, Zhen You, et al.
Advanced Materials (2023)
Closed Access | Times Cited: 36
Extracellular vesicle‐based nucleic acid delivery
Mei Lu, Wanxuan Shao, Haonan Xing, et al.
Deleted Journal (2023) Vol. 1, Iss. 2
Open Access | Times Cited: 32
Biomedical applications of nanomaterials in the advancement of nucleic acid therapy: Mechanistic challenges, delivery strategies, and therapeutic applications
Krishna Yadav, Kantrol Kumar Sahu, Sucheta, et al.
International Journal of Biological Macromolecules (2023) Vol. 241, pp. 124582-124582
Open Access | Times Cited: 31
An Overview of the Stability and Delivery Challenges of Commercial Nucleic Acid Therapeutics
Rahul G Ingle, Wei‐Jie Fang
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1158-1158
Open Access | Times Cited: 29
Targeting materials and strategies for RNA delivery
Lixin Lin, Kexin Su, Qiang Cheng, et al.
Theranostics (2023) Vol. 13, Iss. 13, pp. 4667-4693
Open Access | Times Cited: 26
Non-viral nucleic acid delivery approach: A boon for state-of-the-art gene delivery
Kantrol Kumar Sahu, Madhulika Pradhan, Deependra Singh, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 80, pp. 104152-104152
Closed Access | Times Cited: 24
Engineered Polymer–siRNA Polyplexes Provide Effective Treatment of Lung Inflammation
Taewon Jeon, David C. Luther, Ritabrita Goswami, et al.
ACS Nano (2023) Vol. 17, Iss. 5, pp. 4315-4326
Open Access | Times Cited: 24
Advances in local drug delivery technologies for improved rheumatoid arthritis therapy
Xiaoran An, Jiapei Yang, Xiaolin Cui, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115325-115325
Closed Access | Times Cited: 8
Nanoparticles derived from herbal preparations May represent a novel nucleic acid therapy
T Feng, Waqas Ahmed, Talha Ahmed, et al.
Deleted Journal (2024) Vol. 2, Iss. 2
Open Access | Times Cited: 7
Engineering Logic DNA Nanoprobes on Live Cell Membranes for Simultaneously Monitoring Extracellular pH and Precise Drug Delivery
Wanzhen Chen, Jingjing Lai, Siqi Dong, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 8, pp. 3462-3469
Closed Access | Times Cited: 7
RNA nanostructures for targeted drug delivery and imaging
Laura Teodori, Marjan Omer, Jørgen Kjems
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-19
Open Access | Times Cited: 7
A Bioswitchable MiRNA Delivery System: Tetrahedral Framework DNA-Based miRNA Delivery System for Applications in Wound Healing
Xiaoying Lyu, Haoyan Wu, Mengzhuo Xu, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 26, pp. 33192-33204
Closed Access | Times Cited: 7
Breaking the final barrier: Evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosome
Kaitlin Mrksich, Marshall S. Padilla, Michael J. Mitchell
Advanced Drug Delivery Reviews (2024), pp. 115446-115446
Closed Access | Times Cited: 7
Advanced technologies for the development of infectious disease vaccines
Akash Gupta, Arnab Rudra, Kaelan Reed, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 914-938
Closed Access | Times Cited: 7
mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles
Andreas Ouranidis, Theofanis Vavilis, Evdokia Mandala, et al.
Biomedicines (2021) Vol. 10, Iss. 1, pp. 50-50
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top